(1)
Taskaynatan, H.; Kucukzeybek, Y.; Yildiz, Y.; Salman, T.; Oflazoglu, U.; Varol, U.; Alacacioglu, A.; Saray, S.; Ozdemir, O.; Oktay Tarhan, M. Low Dose (d1-5/7) Oral Etoposide Regimen in Intensively Treated Platinum-Resistant Epithelial Ovarian Cancer: The ─░zmir Oncology Group (IZOG) Study. annalsmedres 2021, 27, 0029-0033.